Whole Foods is now enforcing higher liability insurance requirements, which will affect insurance costs for dietary supplement suppliers.
Poms & Associates (Woodland Hills, CA) reports that Whole Foods is now enforcing higher liability insurance requirements, a move that will adversely affect insurance costs for dietary supplement suppliers.
Companies that don’t meet the requirement would have to pay higher premiums.
Greg Doherty specializes in dietary supplement practices with Poms & Associates. Doherty says he spoke with a Whole Foods insurance broker responsible for the enforcement.
“For the past several years, the insurance requirements for Whole Foods Markets have been unevenly enforced, often on a regional or even local basis, with exceptions made that deviated from corporate guidelines. Virtually without exception, the deviations allowed suppliers to get by with insurance limits less than the corporate mandate. Now Whole Foods Markets has decided to enforce the requirements with a ‘no exceptions’ policy.”
Poms’s solution for the Whole Foods requirement is a newly developed insurance facility that brings companies up to a required $6 million per occurrence and $7 million aggregate.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.
The Nutritional Outlook Podcast Episode 34: Demystifying Prebiotics and Postbiotics
September 30th 2024In this episode of the Nutritional Outlook Podcast we are looking back on a webcast Nutritional Outlook hosted in May, called “Demystifying the Prebiotic and Postbiotic Markets.” During that event, Sandra Saville, director of education and communication for the International Probiotics Association and Dr. Jessica A. Younes, scientific director of the International Probiotics Association debunked myths about prebiotic and postbiotics, and defined the respective categories to help manufacturers better understand how to responsibly formulate and market prebiotic and postbiotic products.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.